UA
Umesh Arunbhai Yagnik
About Umesh Arunbhai Yagnik
Data last updated:
Umesh Arunbhai Yagnik is a Director at Rathin Products Private Limited (since 2013), Director at Yashvi Impex Private Limited (since 2014) and Director at Cellulife Cord Blood Solutions Private Limited (since 2016), and holds 2 more current directorships. The companies operate in Financial Services, Metals and Minerals and Healthcare. The 3 current companies with reported revenue have a combined latest revenue of ₹3.21 Cr; the largest is Rathin Products Private Limited at ₹1.97 Cr (FY 2018). Earlier, Umesh Arunbhai Yagnik was a Director at Cellugen Biotech Private Limited (2016–2022) and Director at Cellmed Biotech Private Limited (2017–2021) and 2 more.
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 06 Sep 2013 | 2013 | ₹1.97 Cr (FY 2018) | Active | |
| Director | 08 Jan 2014 | 2014 | ₹1.11 Cr (FY 2019) | Active | |
| Director | 30 Apr 2016 | 2016 | ₹13 Lakh (FY 2017) | Active | |
| Director | 07 Jun 2021 | 2021 | Active | ||
| Director | 02 Jan 2014 | 2014 | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 25 Mar 2016 | 2008 | ₹14.50 Cr (FY 2019) | Under Cirp | |
| Director | 14 Feb 2017 | 2017 | ₹6.3 Lakh (FY 2025) | Active | |
| Designated Partner | 02 Aug 2021 | 2021 | Active | ||
| Director | 31 Mar 2016 | 2016 | Strike Off |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Umesh Arunbhai Yagnik
| Name | DIN | Company | Designation |
|---|---|---|---|
| Heena Hetal Rajdev | 07174195 | Rathin Products Private Limited | Additional Director |
| Rajivkumar Kalidas Desai | 02300948 | Rathin Products Private Limited | Additional Director |
| Sumitra Umeshkumar Yagnik | 06647500 | Yashvi Impex Private Limited , Acuty Lifescience Private Limited and 1 more | Director |
| Avani Firdosh Mahuvawalla | 01848154 | Cellulife Cord Blood Solutions Private Limited | Additional Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Umesh Arunbhai Yagnik
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Umesh Arunbhai Yagnik
Umesh Arunbhai Yagnik currently holds 5 directorships: Rathin Products Private Limited (Director, since 06 Sep 2013, revenue ₹1.97 Cr (FY 2018)); Yashvi Impex Private Limited (Director, since 08 Jan 2014, revenue ₹1.11 Cr (FY 2019)); Cellulife Cord Blood Solutions Private Limited (Director, since 30 Apr 2016, revenue ₹13 Lakh (FY 2017)); Acuty Lifescience Private Limited (Director, since 07 Jun 2021); Prabhudas Natural Resources Private Limited (Director, since 02 Jan 2014).
Umesh Arunbhai Yagnik was first appointed on 06 Sep 2013 as Director at Rathin Products Private Limited. The most recent appointment on record is 02 Aug 2021 at Njp Infra Llp.
The 3 current companies of Umesh Arunbhai Yagnik that report revenue have a combined latest revenue of ₹3.21 Cr: Rathin Products Private Limited ₹1.97 Cr (FY 2018); Yashvi Impex Private Limited ₹1.11 Cr (FY 2019); Cellulife Cord Blood Solutions Private Limited ₹13 Lakh (FY 2017).
Umesh Arunbhai Yagnik held 4 earlier board appointments: Cellugen Biotech Private Limited (Director, 25 Mar 2016 to 05 Jan 2022); Cellmed Biotech Private Limited (Director, 14 Feb 2017 to 11 May 2021); Njp Infra Llp (Designated Partner, 02 Aug 2021 to 25 Dec 2021); Rigen Biosciences Private Limited (Director, from 31 Mar 2016).
The current boards of Umesh Arunbhai Yagnik's companies include Heena Hetal Rajdev (Rathin Products Private Limited), Rajivkumar Kalidas Desai (Rathin Products Private Limited), Sumitra Umeshkumar Yagnik (Yashvi Impex Private Limited), Avani Firdosh Mahuvawalla (Cellulife Cord Blood Solutions Private Limited).